How Your Thyroid Controls Your Testosterone (Check This Before TRT)
Your hypothalamus and pituitary gland sit at the top of three separate hormonal chains, and every signal your body sends to make testosterone, activate thyroid hormones, and release growth hormone runs through that same relay. The thyroid axis goes first. Then testosterone. Then growth hormone. And that order is not arbitrary, it is mechanistic, which means if the first one is broken, the other two will look broken too, and treating the downstream problem without checking the upstream source is where most protocols go wrong.
Understanding why requires walking the full pathway before zooming in on any single piece.
Your hypothalamus produces something called TRH, or thyrotropin releasing hormone, which travels down to your pituitary gland and prompts it to release TSH, or thyroid stimulating hormone. TSH then signals your thyroid gland to produce two hormones: T4, which makes up roughly 80% of thyroid output and acts as a storage form, and T3, which makes up the remaining 20% and is the form your cells actually use. T4 has to be converted into T3 by a family of enzymes called deiodinases before it does anything biologically useful, and those enzymes require selenium to function. So when selenium is low, T4 accumulates and T3 stays low, and the standard test, TSH alone, never catches this because TSH can look completely normal while the conversion is failing downstream.
There is also a diversion pathway where T4 gets converted into something called reverse T3 instead of active T3, a biologically inert form that competes for the same receptors. Chronic cortisol activates the enzyme responsible for this conversion, which means stress alone can create what looks like hypothyroidism on a functional level while TSH appears normal on a standard panel. Chopra and colleagues showed this diversion happens within hours of cortisol exposure.
That is the thyroid axis. Now here is where it connects to testosterone.
Your testosterone production follows the same relay structure. Your hypothalamus releases GnRH, which signals the pituitary to release LH and FSH, and LH travels to the Leydig cells in your testes to trigger testosterone production. Both systems share the same hypothalamus and pituitary infrastructure, and they do not run independently of each other.
Thyroid hormone controls testosterone production through three distinct mechanisms.
The first is at the pituitary. T3 modulates how strongly your pituitary responds to the GnRH signal coming from your hypothalamus. When T3 is low, the pituitary receives the signal but produces a weakened LH response. The message is sent but the relay station is not amplifying it correctly. This creates a pattern called hypogonadotropic hypogonadism, which is low testosterone paired with low or normal LH, meaning the testes themselves are functional but are not receiving an adequate signal to produce. A 2000 study by Donnelly and White observed this exact pattern in men with primary hypothyroidism and found that free testosterone nearly doubled, from 161 to 315 pmol/L, after thyroxine replacement. The testes were never the problem. The upstream signal was.
The second mechanism is at the Leydig cell itself. Leydig cells have thyroid hormone receptors on them, and T3 increases the number of LH receptors on those cells, which makes them more sensitive to whatever signal they do receive. T3 also upregulates something called StAR protein, or steroidogenic acute regulatory protein, which is the rate-limiting step in testosterone synthesis because it moves cholesterol into the mitochondria where production actually begins. Maran and colleagues measured a 260% increase in StAR protein expression in response to T3. Your thyroid is not just influencing the signal being sent to your testes. It is controlling how much raw material gets moved into the factory where testosterone is built.
The third mechanism involves SHBG, or sex hormone binding globulin, a protein your liver produces that binds to testosterone and renders it biologically inactive. Thyroid status influences how much SHBG your liver makes, which means the same total testosterone number on your bloodwork represents different amounts of usable hormone depending on thyroid function. You cannot interpret testosterone numbers without thyroid context.
A 2022 conference abstract by Shrivastav and Saboo looked at 51 men with overt hypothyroidism and found that 50% had low testosterone at baseline, and that after levothyroxine normalized their thyroid function, 70% of those men had their testosterone return to normal without any testosterone treatment. It is worth being precise about this source: it is a conference abstract, not a peer reviewed study, and the sample is small and from a single center. But the direction is consistent with the Donnelly data and with the mechanisms above.
The same upstream dependency applies to growth hormone. The somatotroph cells in your pituitary that produce growth hormone need adequate T3 to express the receptors that receive the growth hormone releasing signal from the hypothalamus. Miki and colleagues showed that hypothyroidism directly depressed the growth hormone response to GHRH and that T3 treatment restored it. And the pituitary also carries something called the growth hormone secretagogue receptor, which is the receptor that peptides like ipamorelin and MK-677 are designed to activate. Kamegai and colleagues showed in 2001 that T3 increases the expression of this receptor by extending its mRNA half-life from 8 hours to 15 hours in rat pituitary cells. That finding is in vitro and from animal tissue, so human confirmation is lacking, but the mechanism implies that suboptimal thyroid function directly reduces the receptor density that peptide protocols depend on.
So the order of operations is structural, not conceptual. Thyroid hormone controls LH signaling at the pituitary, controls steroidogenic capacity at the Leydig cell, and controls receptor availability for growth hormone signals. If you skip the foundation and treat the downstream numbers, you are not fixing anything. You are compensating for a problem that is still running.
The practical implication is that TSH alone is not sufficient before starting any hormonal protocol. TSH can be normal while free T3 is low and reverse T3 is elevated, a state called functional hypothyroidism that standard panels miss entirely. A full thyroid panel means TSH, free T3, free T4, and reverse T3. Alongside that you want total testosterone, free testosterone, LH to distinguish between primary and secondary hypogonadism, and SHBG for context.
If thyroid function is suboptimal and the cause is nutritional rather than autoimmune, there are specific inputs to address before moving to medication. Selenium at 200 micrograms per day supports the deiodinase conversion pathway and research shows selenium deficiency directly correlates with an elevated T4 to T3 ratio, meaning the raw material is there but the processing is failing. Do not exceed 400 micrograms. Zinc at 30 milligrams daily supports both TRH synthesis and thyroid hormone receptor function. Ferritin should be checked because iron is a component of thyroid peroxidase, the enzyme your thyroid uses to produce T4 and T3 in the first place, and animal research showed iron deficiency reduced thyroid peroxidase activity by 33 to 56%. Iodine is the structural building block of both T4 and T3, but excess iodine can trigger or worsen autoimmune thyroid conditions, so it should only be supplemented if deficiency has been confirmed.
Hashimoto's thyroiditis is the most common cause of hypothyroidism in developed countries and it is autoimmune, meaning no nutritional intervention corrects the underlying process. True hypothyroidism with elevated TSH and low thyroid hormones requires levothyroxine under medical supervision, and over-replacement carries real consequences including bone loss, atrial fibrillation, and anxiety. A physician running a full panel, not just TSH, is not optional in that scenario.
Most hormonal evaluations start at the end of the chain and work backward only if the first treatment does not work. The thyroid axis sits at the top of a system where nearly everything downstream depends on it functioning correctly, and the standard of care does not require checking it before writing a testosterone prescription. That gap between what the mechanism requires and what the protocol actually checks is where a lot of people end up on treatments they may not have needed in the first place.
References
- Donnelly P, White C. 2000. Testicular dysfunction in men with primary hypothyroidism; reversal of hypogonadotrophic hypogonadism with replacement thyroxine. Clinical Endocrinology, 522:197-201. Free testosterone nearly doubled 161 to 315 pmol/L after thyroxine replacement in hypothyroid men. Source
- Shrivastav A, Saboo B. 2022. Effect of levothyroxine replacement therapy on testosterone, LH, FSH levels in men with overt hypothyroidism. ECE2022 Conference Abstract, Endocrine Abstracts, 81, P730. 70% of hypogonadal hypothyroid patients had testosterone normalize after levothyroxine. Conference abstract, N=51. Source
- Maran RR, et al. 2000. Assessment of mechanisms of thyroid hormone action in mouse Leydig cells. Endocrinology, 14112:4468-4477. T3 increases LH receptor numbers, StAR protein 260% increase, and steroidogenic enzyme expression in Leydig cells. Source
- Kamegai J, et al. 2001. Thyroid hormones regulate pituitary growth hormone secretagogue receptor gene expression. Journal of Neuroendocrinology, 133:275-278. T3 increased GHS-R mRNA by extending half-life from 8h to 15h in rat pituitary cells. Source
- Miki N, et al. 1989. Effects of hypothyroidism, T3 and glucocorticoids on GH responses to GHRH. Journal of Endocrinology, 122:585-591. Hypothyroidism depressed growth hormone response to GHRH; T3 treatment restored it. Source
- Winther KH, et al. 2020. Thyroid function in patients with selenium deficiency exhibits high free T4 to T3 ratio. BMC Endocrine Disorders. Selenium deficiency directly associated with impaired T4 to T3 conversion. Source
- Hess SY, et al. 2002. Iron deficiency anemia reduces thyroid peroxidase activity in rats. Journal of Nutrition, 1327:1951-1955. Iron deficiency reduced TPO activity by 33-56%. Source
- Chopra IJ, et al. 1975. Opposite effects of dexamethasone on serum concentrations of reverse T3 and T3. Journal of Clinical Endocrinology and Metabolism. Cortisol shifts T4 metabolism toward reverse T3 within hours. Source
Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness
If this is the kind of information you want access to on a daily basis, the community is free and there are full courses on training, nutrition, hormones, and supplementation inside. You can ask questions and post your own labs and get feedback from me and from the community.